Cytotoxicity and Multi-Enzyme Inhibition of Nepenthes miranda Stem Extract on H838 Human Non-Small Cell Lung Cancer Cells and RPA32, Elastase, Tyrosinase, and Hyaluronidase Proteins
Open Access
Abstract
The carnivorous pitcher plants of the genus Nepenthes have long been known for their ethnobotanical applications. In this study, we prepared various extracts from the pitcher, stem, and leaf of Nepenthes miranda using 100% ethanol and assessed their inhibitory effects on key enzymes related to skin aging, including elastase, tyrosinase, and hyaluronidase. The cytotoxicity of the stem extract of N. miranda on H838 human lung carcinoma cells were also characterized by effects on cell survival, migration, proliferation, apoptosis induction, and DNA damage. The cytotoxic efficacy of the extract was enhanced when combined with the chemotherapeutic agent 5-fluorouracil (5-FU), indicating a synergistic effect. Flow cytometry analysis suggested that the stem extract might suppress H838 cell proliferation by inducing G2 cell cycle arrest, thereby inhibiting carcinoma cell proliferation. Gas chromatography–mass spectrometry (GC–MS) enabled the tentative identification of the 15 most abundant compounds in the stem extract of N. miranda. Notably, the extract showed a potent inhibition of the human RPA32 protein (huRPA32), critical for DNA replication, suggesting a novel mechanism for its anticancer action. Molecular docking studies further substantiated the interaction between the extract and huRPA32, highlighting bioactive compounds, especially the two most abundant constituents, stigmast-5-en-3-ol and plumbagin, as potential inhibitors of huRPA32’s DNA-binding activity, offering promising avenues for cancer therapy. Overall, our findings position the stem extract of N. miranda as a promising source of natural compounds for anticancer therapeutics and anti-skin-aging treatments, warranting further investigation into its molecular mechanisms and potential clinical applications.Keywords
Funding Information
- National Science and Technology Council, Taiwan (NSTC 112-2320-B-040-018, PTH112036)
- Tao Yuan General Hospital, Taiwan (NSTC 112-2320-B-040-018, PTH112036)
This publication has 83 references indexed in Scilit:
- The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activitiesPhytotherapy Research, 2023
- Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activitiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Crystal structure of the single-stranded DNA-binding protein SsbB in complex with the anticancer drug 5-fluorouracil: Extension of the 5-fluorouracil interactome to include the oligonucleotide/oligosaccharide-binding fold proteinBiochemical and Biophysical Research Communications, 2021
- Identification and characterization of dihydropyrimidinase inhibited by plumbagin isolated from Nepenthes miranda extractBiochimie, 2020
- Complexed crystal structure of SSB reveals a novel single-stranded DNA binding mode (SSB)3:1: Phe60 is not crucial for defining binding pathsBiochemical and Biophysical Research Communications, 2019
- Crystal structure of dihydropyrimidinase in complex with anticancer drug 5-fluorouracilBiochemical and Biophysical Research Communications, 2019
- Crystal structure of SSB complexed with inhibitor myricetinBiochemical and Biophysical Research Communications, 2018
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Inhibition effects of (+)-catechin–aldehyde polycondensates on proteinases causing proteolytic degradation of extracellular matrixBiochemical and Biophysical Research Communications, 2004